Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117196) titled 'Using multi-omics to investigate intratumoral heterogeneity and driver genes in early-stage lung cancer' on Jan. 21.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Department of Thoracic Surgery, Second Affiliated Hospital of Army Medical University
Condition:
Lung cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2022-04-01
Target Sample Size: Observation group:200;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=290177
Disclaimer: Curated by HT Syndication....